One of your best @otherperspective. And as always, presented in a clear and simple way for many of us laypersons to understand.
If you have time could you very briefly expand on what approximate % differential figure ( control v treatment) of reductions in MACE , you imagine would fit each category?
For eg:
1. Overwhelming efficiency (40%-100%)
2. Confirmation trial required. (15%- 40% )
3. Fail. ( 0-15%)
* I have no idea
Also do you still hold hope for Feb Headline results if permitted?
MSB Trading - 2020, page-297
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.8¢ |
Change
0.008(0.83%) |
Mkt cap ! $1.033B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 93.5¢ | 89.0¢ | $3.986M | 4.363M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 24582 | 90.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.0¢ | 50759 | 13 |
View Market Depth
| Last trade - 12.04pm 24/04/2024 (20 minute delay) ? |
|
|||||
|
Last
90.5¢ |
Change
0.008 ( 0.33 %) |
||||
| Open | High | Low | Volume | ||
| 91.0¢ | 93.5¢ | 89.0¢ | 1033625 | ||
| Last updated 12.24pm 24/04/2024 ? | |||||
| MSB (ASX) Chart |